BioSpace News Archive

Sandata Technologies, LLC, the leading provider of technology solutions for the homecare market, announced today that The Centers for Medicare & Medicaid Services (CMS) has granted certification of Sandata’s Electronic Visit Verification™ (EVV™) system.

Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL), today announced positive results from an open-label extension Phase 1/2a study, ISO-CC-005, of arfolitixorin as part of the first-line treatment regimen in patients with metastatic colorectal cancer (mCRC).

NYU Winthrop Hospital today announced that Eva Chalas, MD, Physician Director of the Center for Cancer Care, Vice Chair of the Department of Obstetrics and Gynecology, and Professor, NYU Long Island School of Medicine, has been named President Elect of the American College of Obstetricians and Gynecologists

Our athletes are a tremendous source of national pride. Their determination and passion serve as an inspiration for Canadians, especially for young athletes and children in sport who dream of standing on the podium.

The Minister of Indigenous Services, Seamus O’Regan, issued the following statement

Philanthropist Elaine Chambers has been elected to the board of directors of the CDC Foundation. Chambers has a passion for supporting educational and health initiatives both in Northern California, where she resides, as well as nationally.

Since 2017, Make-A-Wish® America has received more than $3 million in charitable donations from Bristol-Myers Squibb Company, including a $500,000 contribution this year, with the purpose of granting more life-changing wishes for children with cancer.

Altasciences won in the Most Successful Early Phase Research category at the 2019 Clinical and Research Excellence Awards.

Phoenix Group and Telesto Digital announced today that they have successfully completed a merger to create eNOVA — the next-generation medical communications company dedicated to eVolutionzing™ customer engagement.

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its first quarter 2019 financial results.